BRAF and cancer: Due to BRAF inhibitors resistance, further studies should be done to understand the molecular mechanism of resistance and to find mutations other than BRAF that are implicated in these cancers to facilitate the development of upcoming-generation inhibitors and improve the patient’s prognosis, survival, and clinical outcomes.